Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa
about
Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cellsProbiotics in prevention of antibiotic associated diarrhoea: meta-analysis.Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.Systematic review and meta-analysis of Saccharomyces boulardii in adult patientsPotential uses of probiotics in clinical practiceThe Microbiota and Health Promoting Characteristics of the Fermented Beverage KefirAlternatives to Antibiotics to Prevent Necrotic Enteritis in Broiler Chickens: A Microbiologist's PerspectiveProbiotic use in horses - what is the evidence for their clinical efficacy?Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implicationsInfluence of Saccharomyces boulardii CNCM I-745on the gut-associated immune systemGut bacteria in health and diseaseCapric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formationSaccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cellsBacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologistsLactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cellsMicrobiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactionsProbiotics-host communication: Modulation of signaling pathways in the intestine.Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic ScienceA Double-Blind, Randomized, Active Drug Comparative, Parallel-Group, Multi-Center Clinical Study to Evaluate the Safety and Efficacy of Probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in Patients with Diarrhea.Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii.Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation.Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition.Pathogenesis and treatment of Clostridium difficile infectionModulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory DiseasesClostridium difficile infection: new insights into management.Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii.Clinical update for the diagnosis and treatment of Clostridium difficile infection.Treatment of Recurrent Clostridium difficile DiarrheaBeneficial effects of probiotic and food borne yeasts on human healthEfficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.Antimicrobial and probiotic properties of yeasts: from fundamental to novel applicationsThe role of probiotics and prebiotics in inducing gut immunity.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxinSaccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment.Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins.
P2860
Q21198789-6A9C6153-2A22-450C-9AD1-67F2E5ACD459Q24529831-74EA2C73-E0C7-46D0-8030-02889F104CC2Q24545538-A29E0F91-22EA-4E00-92E1-41F09F36D1A7Q24621081-0F893D6E-F001-46E7-86BB-5694052D60E5Q24681377-8E7C1708-1DFC-49F9-AA1F-7AE1D5D1CBB7Q26747430-A7734147-5EE1-4EAE-B997-05C9CE965E7EQ26773141-738CA51E-5205-4186-BF78-2F884742FC09Q27021831-0D7896F8-4C04-48AE-9F13-67D3C59FDB21Q27027602-C43E1B67-81B5-4FDE-AF64-DB67C1799FA0Q28066899-A872AEF6-55E7-4F1F-9805-D23F126A8AB4Q28238138-870CA124-12B3-412D-9B03-A383F48B3D2AQ28475053-A50876A6-9910-4661-9555-16E22B0C29B5Q28741411-E45BD91E-027C-4006-B6FF-606433F976D2Q28741795-2BF64B29-1DC8-41BD-BC5F-917D60C5B43AQ33890323-CE40DB25-03E6-45B0-81D4-FB46B3D6B699Q33958897-680DD7B1-FEA6-4443-9115-0595C3E42947Q34018028-2E8215BC-2DA0-48D0-8F64-7550292E5549Q34162963-C2FC3CB5-D7FE-4147-B662-3684554EE156Q34378800-E79B9902-85C4-4F65-AAD1-35A688729CDCQ34554028-3CF581A5-EFFB-4A42-A91B-2889D4FA4F42Q34723329-FF242BD9-2D9E-4567-AF96-9057ED0F6AE6Q35540167-4482CBF7-43A0-4A4E-A683-65639F592E72Q35621330-DDFA07ED-84BE-4E92-9E37-CF4610E03453Q36152528-7958E43D-BC46-4698-91ED-C45FCF3A06F3Q36449677-218070F8-1130-47E9-AB9E-BE9CFA4579E2Q36523440-D76BADFA-06E9-47FE-8D3B-C7FA89A78FC1Q37009989-61F530BA-5DF3-4D15-8E88-FAC3CE0F485BQ37586528-CBA15527-E425-4F9F-B85C-B8E840EC70F6Q37633859-DF2EA559-946E-4186-858A-DB041741C21BQ37678919-B49FBE58-AFB5-4311-9717-9AAD3A6DA34EQ37976693-0D97F02D-D31F-4097-AED2-EBD8A9DBB21DQ37994188-411725B0-F984-4D47-AB72-533ED99B1C09Q38069827-4C0BAA66-137D-421B-95D3-182C51EEC7D7Q38174603-4B111B5F-DB58-4749-BFD7-489C21E8F1A2Q38794312-7BD709F7-B9C0-4358-AF28-88E514A7D3C8Q38822566-855EAF06-5B9F-47AA-8687-43306BC0C9CEQ39519683-F5AE713F-F5A5-4183-A6FD-94C7A987E606Q40099400-34FF053F-0C8D-4F7D-B013-DFF3FABEDEC9Q40579622-CBDE02C6-2005-4E9D-A756-8BF6C6587D8BQ41824565-BCB4732E-151F-4C55-9EDF-AD22323D32F5
P2860
Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@ast
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@en
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@nl
type
label
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@ast
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@en
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@nl
prefLabel
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@ast
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@en
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@nl
P2093
P2860
P3181
P1476
Saccharomyces boulardii protea ...... and B in human colonic mucosa
@en
P2093
C Pothoulakis
I Castagliuolo
J T LaMont
L Valenick
M F Riegler
P2860
P3181
P356
10.1016/S0016-5085(98)83862-6
P407
P577
1999-01-01T00:00:00Z